Biologically pure culture of Nocardiopsis trehalosei sp. nov.
AssigneeThe Upjohn Company
InventorsLester A. Dolak, Alice L. Laborde, Thomas M. Castle
Life of this patent
Estimating the term…
Abstract
Novel antibiotic 3-trehalosamine (U-59,834) producible in a fermentation under controlled conditions using the new microorganism Nocardiopsis trehalosei sp. nov., NRRL 12026. This antibiotic is active against Gram-positive bacteria, for example, Staphylococcus aureus, Bacillus subtilis, and Diplococcus pneumoniae. Thus, 3-trehalosamine can be used in various environments to eradicate or control such bacteria. Antibiotic 3-trehalosamine can be shown by the following structural formula: ##STR1##
Claims1
A biologically pure culture of the microorganism Nocardiopsis trehalosei sp. nov. having the identifying characteristics of NRRL 12026, said culture being capable of producing the antibiotic 3-trehalosamine in a recoverable quantity upon fermentation in an aqueous nutrient medium containing assimilable sources of carbon, nitrogen and inorganic substances.
Dependencies are inferred from the claim text.